AustralianSuper Pty Ltd Has $100.99 Million Holdings in Colgate-Palmolive Company $CL

AustralianSuper Pty Ltd lowered its position in Colgate-Palmolive Company (NYSE:CL) by 2.8% during the third quarter, according to its most recent filing with the SEC. The firm owned 1,263,266 shares of the company’s stock after selling 35,727 shares during the period. AustralianSuper Pty Ltd’s holdings in Colgate-Palmolive were worth $100,985,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of the company. Norges Bank acquired a new position in Colgate-Palmolive in the second quarter valued at $960,390,000. Schroder Investment Management Group raised its position in shares of Colgate-Palmolive by 242.3% in the 2nd quarter. Schroder Investment Management Group now owns 5,324,115 shares of the company’s stock worth $483,962,000 after acquiring an additional 3,768,784 shares in the last quarter. Pacer Advisors Inc. lifted its stake in shares of Colgate-Palmolive by 3,052.2% in the 3rd quarter. Pacer Advisors Inc. now owns 2,697,047 shares of the company’s stock valued at $215,602,000 after purchasing an additional 2,611,485 shares during the period. Acadian Asset Management LLC boosted its position in shares of Colgate-Palmolive by 42.9% during the 2nd quarter. Acadian Asset Management LLC now owns 6,124,347 shares of the company’s stock valued at $556,663,000 after purchasing an additional 1,839,853 shares in the last quarter. Finally, OMERS ADMINISTRATION Corp grew its stake in Colgate-Palmolive by 2,890.5% during the second quarter. OMERS ADMINISTRATION Corp now owns 1,417,542 shares of the company’s stock worth $128,855,000 after purchasing an additional 1,370,140 shares during the period. 80.41% of the stock is currently owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Performance

Shares of Colgate-Palmolive stock opened at $85.08 on Thursday. Colgate-Palmolive Company has a 52 week low of $74.54 and a 52 week high of $100.18. The company has a quick ratio of 0.60, a current ratio of 0.93 and a debt-to-equity ratio of 5.90. The business has a 50 day moving average price of $80.46 and a 200-day moving average price of $81.39. The company has a market cap of $68.58 billion, a PE ratio of 23.83, a price-to-earnings-growth ratio of 5.78 and a beta of 0.30.

Colgate-Palmolive (NYSE:CL) last announced its quarterly earnings results on Friday, October 31st. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.89 by $0.02. The business had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.17 billion. Colgate-Palmolive had a return on equity of 333.39% and a net margin of 14.47%.Colgate-Palmolive’s revenue was up 1.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.91 earnings per share. Equities analysts anticipate that Colgate-Palmolive Company will post 3.75 earnings per share for the current fiscal year.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Wednesday, January 21st will be given a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.4%. The ex-dividend date of this dividend is Wednesday, January 21st. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 58.26%.

Analyst Upgrades and Downgrades

CL has been the subject of several recent analyst reports. Morgan Stanley reduced their price objective on shares of Colgate-Palmolive from $96.00 to $87.00 and set an “overweight” rating for the company in a research report on Monday, November 3rd. TD Cowen reduced their price target on shares of Colgate-Palmolive from $90.00 to $86.00 and set a “buy” rating for the company in a report on Thursday, January 8th. Jefferies Financial Group set a $85.00 price objective on shares of Colgate-Palmolive in a research report on Tuesday, December 16th. Royal Bank Of Canada raised Colgate-Palmolive from a “sector perform” rating to an “outperform” rating and set a $88.00 target price for the company in a research report on Tuesday, December 9th. Finally, UBS Group upped their price target on Colgate-Palmolive from $90.00 to $93.00 and gave the stock a “buy” rating in a research note on Wednesday, January 14th. Eleven equities research analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, Colgate-Palmolive has a consensus rating of “Moderate Buy” and an average target price of $89.44.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.